Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies

Konference: 2012 54th ASH Annual Meeting - účast ČR

Téma: 604. Molecular Pharmacology, Drug Resistance

Číslo abstraktu: 0284

Autoři: Simona Soverini; Caterina De Benedittis; Mgr. Kateřina Machová (Poláková), Ph.D.; Ing. Adéla Benešová (Broučková), Ph.D.; M.D. Cristina Papayannidis; Paola Bresciani; Valeria Coluccio; Ilaria Iacobucci, PhD; Claudia Venturi; Mario Luppi; Emanuela Ottaviani; Federica Cattina; Robert (Robin) Foa (Foà); MD Antonella Vitale; Prof. Domenico Russo; MD Michele Baccarani; Prof.MD Giovanni Martinelli

Datum přednesení příspěvku: 10. 12. 2012